Taken together, these data verified the ability of sc-Src and sp-Src levels to predict survival in patients with advanced stages of NPC, though the clinical significance of sp-Src was limited in advanced stage and the statistical significance was marginal. The gene discussed is SRC; the disease is nasopharyngeal carcinoma.